Purchase Order 36C24225P1147
Award Date
6/26/25
Potential Completion Date
7/7/25
Potential Value
$13K
Federal Agency
Veterans Integrated Service Network 2
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Orlando, FL 32808, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) tablets to the VA's Veterans Integrated Service Network 2 (VISN 2) facilities. The contract has a ceiling value of $13,242.99 and a period of performance through August 27, 2025. The contract does not...
This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain, for the supply of Jynarque (tolvaptan) 45/105mg tablets. The contract has a ceiling value of $12,580.72 and a period of performance through October 18, 2024. Walgreens Specialty Pharmacy is the prime contractor on this contract, with no subcontractors or set-aside...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 to Walgreens Specialty Pharmacy, LLC, a for-profit subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 contract is for the emergency supply of the prescription medication Jynarque 45 mg - 15 mg to the Northport VA Medical Center, with a completion date of June 6, 2025. The contract has no set-aside designation, indicating it was open to all qualified...
This federal contract award, with an ID of 36C24225P0094, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Walgreens Specialty Pharmacy, LLC, doing business as Walgreens, as the prime contractor. The $12,580.72 firm fixed price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets to VA facilities. Walgreens Specialty Pharmacy, a for-profit organization, has been providing specialized pharmaceutical...
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain. The contract is for the delivery of the specialized pharmaceutical product Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order contract with a period of performance ending...
This firm fixed-price purchase order contract was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $75,208.70 contract is for the provision of pharmaceutical products, with a focus on specialized medications for rare, chronic, or complex medical conditions, such as Jynarque (tolvaptan) for autosomal dominant polycystic kidney disease. The contract does not have a...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The...
This federal contract award is for the delivery of the medication Jynarque (tolvaptan) to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) facilities within the Veterans Integrated Service Network 2 (VISN 2). The $12,580.72 firm fixed price purchase order was awarded to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain, on October 2, 2024. The contract has an ultimate completion date of October 3, 2024 and does not utilize any...
This federal contract award, with an ID of 36C24225P0469, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 firm fixed-price purchase order is for the delivery of the medication Jynarque (tolvaptan) 45mg/15mg tablets. This award does not have a set-aside designation, meaning it was open to all qualified vendors. The contract has an...
This federal contract award, valued at $12,580.72, was issued by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to the prime contractor, Walgreens Specialty Pharmacy, LLC (doing business as Walgreens). The contract is for the delivery of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. This is a firm fixed-price purchase order with a completion date of February 13, 2025. Walgreens Specialty...